Tazarotene 0.1% Topical

Tazarotene 0.1% Topical is a medicine used in the treatment of psoriasis. It works by stopping the overgrowth and thickening of skin cells. Use it only on the affected areas and do not apply on the healthy skin. Tazarotene 0.1% Topical is for external use only. You should always use it exactly as your doctor has told you. The affected area should be clean and dry before application. You must wash your hands thoroughly before and after applying this medicine. This medicine should be used regularly to get the most benefit from it. Do not use more than you need as it will not clear your condition faster and some side effects may be increased. If your condition goes on for longer than four weeks or gets worse at any time, let your doctor know. You can help this medicine work better by keeping the affected areas clean. Common side effects include itching, skin redness, irritation, dry skin, skin burn, and skin peeling at the site of application. Most of these are temporary and usually resolve with time. Please consult your doctor if these side effects persist for a longer duration. Avoid direct contact of the cream or ointment with your eyes. In case of direct contact, wash your eyes with water and seek immediate medical attention. Avoid sun exposure and cover the treated areas with clothing or use a sunscreen before stepping out in the sun. Before taking this medicine, you should tell your doctor if you are pregnant, planning pregnancy or breastfeeding as it may lead to birth defects. Tazarotene 0.1% Topical is a form of vitamin A. It works by slowing down the rapid growth of skin cells, and blocks certain substances which cause inflammation (redness and swelling) on skin. This reduces scaling and thickening of the skin in psoriasis and clears acne.

• Psoriasis • Acne

Tazarotene is a synthetic acetylenic retinoid, that is applied topically. It is de-esterified in the skin to its active form, tazarotenic acid, which affects cell proliferation and differentiation by modulating gene expression in acne and psoriasis.

Adult Dose: Topical/Cutaneous Acne, Stable plaque psoriasis Apply a thin layer to cleansed dry affected area, once daily in the evening. Photoaging Adult: Apply a thin layer to cover entire face (including eyelids) once daily before going to bed. Child Dose: 12 years: Apply to affected area once daily in the evening.

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying, unless hands are the affected area.

Common: • Dry skin • Erythema (skin redness) • Itching • Skin burn • Skin irritation • Skin peeling

No interaction found/established Tazarotene 0.1% Topical should be applied as per dose and duration suggested by the doctor. Finish the full course of treatment even if you feel better. Wash your hands properly before and after applying the medicine. Avoid getting in the eyes, nose, or mouth. If accidental exposure occurs, rinse immediately with plenty of water. Avoid exposing your skin to strong sunlight, use a sunscreen lotion or make sure your skin is protected with clothing. Do not cover the area being treated with airtight dressings such as bandages unless directed by a doctor, as this may increase the risk of side effects. Inform your doctor if the infection has not cleared up after four weeks of treatment.

Pregnancy, lactation. Eczema. Sunburnt conditions. Hypersensitivity.

Increased drying effect effect with concomitant use of dermatologic medications and cosmetics that have irritant or strong drying effect. Increased risk of photosensitivity with drugs known to be photosensitisers.

No interaction found/established

[UNSAFE] Tazarotene 0.1% Topical is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

[CONSULT YOUR DOCTOR] Tazarotene 0.1% Topical is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

No interaction found/established No interaction found/established